GENTILCORE, Elena
 Distribuzione geografica
Continente #
NA - Nord America 486
EU - Europa 207
AS - Asia 119
SA - Sud America 8
Totale 820
Nazione #
US - Stati Uniti d'America 485
CN - Cina 52
SE - Svezia 38
IE - Irlanda 32
DE - Germania 30
SG - Singapore 27
UA - Ucraina 22
FR - Francia 20
IT - Italia 19
FI - Finlandia 16
KR - Corea 12
RU - Federazione Russa 9
PL - Polonia 8
AT - Austria 7
BR - Brasile 7
ID - Indonesia 6
GB - Regno Unito 5
IN - India 5
VN - Vietnam 5
JP - Giappone 4
HK - Hong Kong 3
AE - Emirati Arabi Uniti 2
CA - Canada 1
EC - Ecuador 1
NL - Olanda 1
SA - Arabia Saudita 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 820
Città #
Fairfield 51
Beijing 40
Chandler 38
Seattle 37
Santa Clara 36
Ashburn 35
Dublin 32
Woodbridge 26
Dearborn 21
Houston 21
Wilmington 21
Ann Arbor 20
Singapore 20
Pisa 16
Cambridge 13
Princeton 13
Villeurbanne 13
Jacksonville 11
Medford 11
Nyköping 9
Warsaw 8
West Jordan 8
Columbus 7
Los Angeles 6
Dong Ket 5
Pune 5
Vienna 5
Jakarta 4
Boardman 3
Fremont 3
Hong Kong 3
Phoenix 3
Boston 2
Dubai 2
Guangzhou 2
Hefei 2
Medan 2
Norwalk 2
San Diego 2
San Mateo 2
Araçatuba 1
Belém 1
Campinas 1
Clifton 1
Corrente 1
Cuenca 1
Dallas 1
Edinburgh 1
Falls Church 1
Foshan 1
Groaíras 1
Groningen 1
Huzhou 1
Kharkiv 1
Kunming 1
Milan 1
Mountain View 1
Nanchang 1
Nanjing 1
Ottawa 1
Paris 1
Pyatigorsk 1
Pé de Serra 1
Redwood City 1
Shenyang 1
Songkhla 1
Stockholm 1
Taizhou 1
Tappahannock 1
Tashkent 1
Torino 1
Verona 1
Washington 1
Zhengzhou 1
Totale 594
Nome #
Metabolic significance of hepatic steatosis in non alcoholic fatty liver disease and HCV chronic hepatitis 152
Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C 151
Increased liver expression of inflammatory mediators is associated with hepatic insulin resistance in lean, non-diabetic patients with chronic hepatitis C. 138
Increased liver expression of inflammatory mediators is associated with hepatic insulin resistance in lean, non-diabetic CHC patients. 136
Incidence of Type 2 diabetes mellitus and glucose abnormalities in treated patients with chronic hepatitis C infection: results of a controlled follow-up study. 112
Metabolic significance of hepatic steatosis in non alcoholic fatty liver disease and chronic hepatitis C. 60
Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis 52
Gamma-glutamyltransferase activity and insulin resistance in chronic hepatitis C 39
Totale 840
Categoria #
all - tutte 2.445
article - articoli 0
book - libri 0
conference - conferenze 1.570
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.015


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013 0 0 0 0 0 0 0 0 0 7 3 3
2020/202166 9 7 3 4 4 2 3 2 9 5 9 9
2021/202287 0 2 0 10 6 3 3 7 4 24 8 20
2022/2023126 17 6 2 9 12 36 10 11 12 0 8 3
2023/202462 7 10 2 1 5 14 1 1 0 13 3 5
2024/2025111 3 5 8 10 39 29 2 2 3 10 0 0
Totale 840